Australia, 20 FEB 2026 – The Australian government has taken a significant step in enhancing patient safety with the introduction of Unique Device Identification (UDI) requirements for medical devices. Effective from February 2026, this initiative, backed by the Therapeutic Goods Administration (TGA), aims to improve traceability, support post-market surveillance, and make regulatory actions like recalls faster and more efficient. As manufacturers, suppliers, and sponsors, it’s crucial to understand these new UDI requirements and how they affect the medical device supply chain. Here’s what you need to know.
WHY UDI MATTERS FOR MEDICAL DEVICE MANUFACTURERS
The UDI system assigns a unique identifier to each medical device, linking a specific model to its production run. This powerful tool is designed to make tracking devices easier, especially when they’re implanted in patients. In the event of an adverse event or safety recall, the UDI allows health professionals and regulators to pinpoint and remove the affected devices from circulation, reducing the risk of harm.
For medical device manufacturers, particularly those operating under TGA regulations in Australia, the ability to trace and track Australian medical devices after they’ve reached the market ensures faster action when safety issues arise, such as those seen in past device-related crises like hip implants and breast implants.
WHAT DOES THE UNIQUE DEVICE IDENTIFICATION SYSTEM INVOLVE?
The UDI is made up of two parts:
- UDI Device Identifier (UDI-DI): This is the core identifier for a device model. It’s used to distinguish the specific type of device.
- UDI Production Identifier (UDI-PI): This identifier tracks production details, such as batch numbers, expiration dates, and manufacturing runs.
Manufacturers must ensure that UDI-DI and UDI-PI are included on device packaging, labels, and in some cases, directly on the device itself.
WHO NEEDS TO COMPLY?
Not all devices are subject to these requirements. The TGA has based the scope of UDI compliance on a device’s risk classification:
- Class Is, IIa, IIb, III medical devices must comply.
- Class I non-measuring devices and custom-made devices are exempt.
However, it’s recommended that even if your device is exempt, you consider applying UDI voluntarily. This minimizes confusion in healthcare settings and ensures consistent traceability across all devices.
KEY CHALLENGES AND SOLUTIONS IN UNIQUE DEVICE IDENTIFICATION COMPLIANCE
One major challenge for manufacturers is the direct marking of devices, especially reusable devices. For example, surgical instruments that are used on different patients must be directly marked with a UDI to ensure they can be identified after being sterilized and reprocessed. Small, non-sterile devices in Surgical Loan Kits (SLKs) also pose challenges as these devices can lose their UDI markers during sterilization.
To overcome these hurdles, flexible solutions such as stickers, tags, or inventory sheets can be used to maintain compliance. Additionally, manufacturers should consult with TGA-recognized Issuing Agencies to find the most practical methods for direct marking and UDI placement.
UDI REQUIREMENTS AND SPECIFIC DEVICE TYPES
 Different device types have different UDI requirements:
- Software as a Medical Device (SaMD): Apps and software must be assigned their own UDI-DI and software versioning must be tracked.
- Reusable Devices: Must have a UDI directly marked on the device, especially if reprocessed for use on another patient.
- Implantable Devices: These must be easily identifiable via UDI before implantation, including direct marking where applicable.
For devices that are sold in retail, there are reduced labelling requirements. However, if these devices are redirected to healthcare settings, full UDI labelling will be required.
HOW (UDI) UNIQUE DEVICE IDENTIFICATION ENHANCES MARKET OVERSIGHT
The UDI system not only improves traceability but also strengthens market oversight. If a device needs to be recalled, the UDI allows the manufacturer to quickly identify the batch, lot, and serial number of the affected products, minimizing the time it takes to prevent further use. This regulatory transparency ensures that any market actions, such as recalls or adverse event reports, can be conducted smoothly.
WHAT HAPPENS IF YOU DON’T COMPLY UDI REQUIREMENTS?
Non-compliance with UDI regulations can lead to suspension or cancellation of devices from the Australian Register of Therapeutic Goods (ARTG), and in some cases, civil penalties may apply. Manufacturers and sponsors must make sure they meet UDI requirements by the compliance date to avoid disruptions in their product’s market presence.
CONCLUSION
The implementation of UDI marks a significant advancement in medical device regulation in Australia. While compliance may require adjustments to how devices are labelled, packaged, and tracked, the benefits far outweigh the challenges. Manufacturers and sponsors need to stay informed and proactive to ensure patient safety, regulatory transparency, and smooth market operations. For manufacturers, early compliance with UDI requirements not only supports regulatory obligations but also enhances brand integrity and builds trust with healthcare providers and patients.